BURLINGTON, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences in December.
David Roberts, President, will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024, at the Lotte New York Palace in New York City. The company’s presentation is scheduled for 3:30 PM EST.
He is also scheduled to present at the Stifel “MedTech Madness” West Coast Bus Tour at the Rosewood Sand Hill in Menlo Park, CA on Thursday, December 12, 2024, at 11:45 AM PST.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:
Gregory Manker
Director, Business Development & Investor Relations
LeMaitre Vascular, Inc.
+1-781-362-1260
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$92.12 |
| Daily Change: | -0.13 -0.14 |
| Daily Volume: | 367,631 |
| Market Cap: | US$2.070B |
December 16, 2024 October 31, 2024 August 01, 2024 May 02, 2024 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
